Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Yahoo! Finance
REDWOOD CITY, Calif. & BOSTON, February 01, 2023--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on January 31, 2023.
Continue Reading